The survey allowed to identify organizational weaknesses. Overall score was very satisfactory, yet improvable. Future surveys are required for result comparisons and continual improvement assessment.
Introducción. La pandemia de la COVID-19 representa un desafío para los sistemas de salud en el mundo. Esto se debe a que la carga laboral recae sobre su personal y se traduce en estrés, ansiedad y otros problemas de salud mental. Métodos. Se realizó una revisión de la literatura disponible en distintos buscadores científicos (Pubmed, Medline, Scopus, Google Scholar) y en la página web de la Organización Mundial de la Salud (OMS) de enero a julio del 2020. Los artículos incluidos en la revisión debieron estar publicados en revistas indizadas. Desarrollo. Los trabajadores de la salud experimentaron más estrés, ansiedad, insomnio y síntomas de depresión que el resto de la población. Adicionalmente, se identificó factores de riesgo que predisponen a alteraciones en su bienestar mental como ser mujer, personal de enfermería o estudiantil, la infodemia y la desinformación. Conclusión. Es necesario el monitoreo del bienestar mental de los trabajadores de la salud mediante la telemedicina y el apoyo psicológico para brindar atención a quienes experimentan estos problemas de salud, así como implementar campañas de concientización y proporcionar equipo de protección adecuado al personal de salud.
BackgroundBecause of the complex transfer process of one university hospital, it became necessary for the pharmacy service to distribute its activities in both locations (old and new) for 6 weeks. A system for validation and distribution to provide adequate service to patients treated at the facilities of the new hospital was established.PurposeTo assess the level of satisfaction and, if feasible, to identify reasons for dissatisfaction of hospital staff during the transfer process regarding the services provided by the oncology pharmacy unit (OPU).Material and methodsCross sectional study through a self-administered questionnaire distributed to hospital staff to which the preparations made in the OPU are intended. The document contained the same closed questions regarding the pre- and post-transfer periods. In addition, a rating scale of 5 points to evaluate the service provided by the OPU was included.Results38 professionals answered the questionnaire (16 physicians, 15 nurses and 7 nursing assistants). Most (86.8%) developed their activity in outpatient clinics. Prior to the transfer, 92.1% considered their personal activity would be affected somewhat or a lot and 76.3% considered that the security of the patients would be affected somewhat or a lot. Following the transfer, the response rates for these same items were lower (84.2% and 42.1%, respectively). The main concerns expressed a priori by respondents were regarding waiting times (n = 28) and potential errors in transcription and preparation (n = 11). Only 3 respondents reported problems a posteriori, always in relation to waiting times. The assessment of the pharmacist performance was good or very good in 89.4% of cases. Evaluation of the cover slot and compliance with the agreed schedule was good or very good in 68.4% of cases. The overall assessment of this period was better than expected in 65.8% of cases.ConclusionThe performance of the OPU, adapting its activity to the provisional situation of the transfer in order to provide quick, safe and quality patient care, was highly valued by the professionals. Previous expectations were improved. Problems were reported by a few respondents and were always related to waiting times, and never to quality of care or patient safety.No conflict of interest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.